Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Learn why young investors should prioritize compounding in their financial strategy. Early investments can yield significant long-term benefits.
28,299 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
As toyota's challenging u.s. business tests the automaker, investors watch for strategies that could yield a Maverick...
Oklo stock just popped on news that the Department of Energy opened talks with multiple firms. This article breaks do...
Nu Holdings has fallen sharply, with the stock down 37% from its 52-week high. This guide explains what an investor s...
Amazon's potential shift to selling its Trainium AI chips could shake up the AI hardware landscape. This article brea...
Cerebras Systems jumped after its IPO, but is it too late to join the rally? This guide breaks down the tech, market ...
A leading analyst signals more upside for CVS Health as Medicare-related momentum builds. Learn the key drivers, risk...
A growing trend centers on the HSA receipt trick: medical bills, a tax-free growth strategy that lets you reimburse p...
Alphabet's stock has shown resilience amid AI-driven momentum and cloud growth. This guide breaks down whether google...
Cathie Wood Goes Bargain highlights how Ark Invest’s founder targets beaten-down growth bets for long-term gains. Her...
A Senate Banking Committee vote signaling bipartisan support for the CLARITY Act could unlock a clearer path for Bitc...
NVIDIA stock has surprised some by not rallying in 2026 despite booming AI demand. This article breaks down why the s...